Voxel Sa operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Voxel Sa with three other
pharmaceutical manufacturers in Europe:
Atrys Health SA
sales of 6.04 million Euro [US$6.81 million]
Medica Group PLC
of the United Kingdom
(£33.72 million [US$43.28 million]
of which 50%
was NightHawk), and
Oncimmune Holdings PLC
based in the United Kingdom
(£215,000.00 [US$275,995.50 ]
of which 100%
was Distribution of testing products).
Voxel Sa reported sales of 152.16 million Polish New Zlotys (US$39.65 million)
December of 2017.
increase of 26.1%
versus 2016, when the company's sales were 120.66 million Polish New Zlotys.
Sales of It Products and Lab Equipment saw an increase
that was more than double the company's growth rate: sales were up
62.8% in 2017, from
32.04 million Polish New Zlotys to 52.17 million Polish New Zlotys.
Voxel Sa also saw significant increases in sales in
Production of Radiopharmaceuticals (up 58.4% to 2.91 million Polish New Zlotys)
Not all segments of Voxel Sa experienced an increase in sales in 2017:
sales of Other Segments fell 2.1% to 1.80 million Polish New Zlotys.
(However, this segment's sales were only a very small portion of the company's overall sales).